U.S., Aug. 27 -- ClinicalTrials.gov registry received information related to the study (NCT07141277) titled 'GRANITE: Airsupra Effectiveness in the Real World' on July 11.
Brief Summary: The GRANITE study aims to evaluate the effectiveness of Airsupra versus albuterol in reducing asthma exacerbation risk in a real-world US population.
Study Start Date: July 09
Study Type: OBSERVATIONAL
Condition:
Asthma
Intervention:
OTHER: None (Observational study)
Not applicable since it's an observational study.
Recruitment Status: RECRUITING
Sponsor: AstraZeneca
Disclaimer: Curated by HT Syndication....